Alpine Immune Sciences, Inc., a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer, autoimmune/inflammatory, and other diseases, provided a corporate update and reported financial results for the year ended December 31, 2018.
March 18, 2019
· 11 min read